477 related articles for article (PubMed ID: 33527898)
1. Seizures are a druggable mechanistic link between TBI and subsequent tauopathy.
Alyenbaawi H; Kanyo R; Locskai LF; Kamali-Jamil R; DuVal MG; Bai Q; Wille H; Burton EA; Allison WT
Elife; 2021 Feb; 10():. PubMed ID: 33527898
[TBL] [Abstract][Full Text] [Related]
2. Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects.
Alyenbaawi H; Allison WT; Mok SA
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33121065
[TBL] [Abstract][Full Text] [Related]
3. Traumatic brain injury (TBI) in collision sports: Possible mechanisms of transformation into chronic traumatic encephalopathy (CTE).
VanItallie TB
Metabolism; 2019 Nov; 100S():153943. PubMed ID: 31610856
[TBL] [Abstract][Full Text] [Related]
4. Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?
Collins-Praino LE; Corrigan F
Brain Behav Immun; 2017 Feb; 60():369-382. PubMed ID: 27686843
[TBL] [Abstract][Full Text] [Related]
5. Association between single moderate to severe traumatic brain injury and long-term tauopathy in humans and preclinical animal models: a systematic narrative review of the literature.
Walker A; Chapin B; Abisambra J; DeKosky ST
Acta Neuropathol Commun; 2022 Jan; 10(1):13. PubMed ID: 35101132
[TBL] [Abstract][Full Text] [Related]
6. Antiepileptic Drugs as Potential Dementia Prophylactics Following Traumatic Brain Injury.
Locskai LF; Alyenbaawi H; Allison WT
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():577-598. PubMed ID: 37788493
[TBL] [Abstract][Full Text] [Related]
7. Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy.
Kondo A; Shahpasand K; Mannix R; Qiu J; Moncaster J; Chen CH; Yao Y; Lin YM; Driver JA; Sun Y; Wei S; Luo ML; Albayram O; Huang P; Rotenberg A; Ryo A; Goldstein LE; Pascual-Leone A; McKee AC; Meehan W; Zhou XZ; Lu KP
Nature; 2015 Jul; 523(7561):431-436. PubMed ID: 26176913
[TBL] [Abstract][Full Text] [Related]
8. Rapid accumulation of endogenous tau oligomers in a rat model of traumatic brain injury: possible link between traumatic brain injury and sporadic tauopathies.
Hawkins BE; Krishnamurthy S; Castillo-Carranza DL; Sengupta U; Prough DS; Jackson GR; DeWitt DS; Kayed R
J Biol Chem; 2013 Jun; 288(23):17042-17050. PubMed ID: 23632019
[TBL] [Abstract][Full Text] [Related]
9. Tauopathy in veterans with long-term posttraumatic stress disorder and traumatic brain injury.
Mohamed AZ; Cumming P; Götz J; Nasrallah F;
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1139-1151. PubMed ID: 30617964
[TBL] [Abstract][Full Text] [Related]
10. Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.
Kulbe JR; Hall ED
Prog Neurobiol; 2017 Nov; 158():15-44. PubMed ID: 28851546
[TBL] [Abstract][Full Text] [Related]
11. Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: characterization of a novel model and systematic review of the literature.
Kahriman A; Bouley J; Smith TW; Bosco DA; Woerman AL; Henninger N
Acta Neuropathol Commun; 2021 Jun; 9(1):118. PubMed ID: 34187585
[TBL] [Abstract][Full Text] [Related]
12. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation.
Paquet D; Bhat R; Sydow A; Mandelkow EM; Berg S; Hellberg S; Fälting J; Distel M; Köster RW; Schmid B; Haass C
J Clin Invest; 2009 May; 119(5):1382-95. PubMed ID: 19363289
[TBL] [Abstract][Full Text] [Related]
13. Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein.
Rubenstein R; Chang B; Grinkina N; Drummond E; Davies P; Ruditzky M; Sharma D; Wang K; Wisniewski T
Acta Neuropathol Commun; 2017 Apr; 5(1):30. PubMed ID: 28420443
[TBL] [Abstract][Full Text] [Related]
14. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy.
McKee AC; Cairns NJ; Dickson DW; Folkerth RD; Keene CD; Litvan I; Perl DP; Stein TD; Vonsattel JP; Stewart W; Tripodis Y; Crary JF; Bieniek KF; Dams-O'Connor K; Alvarez VE; Gordon WA;
Acta Neuropathol; 2016 Jan; 131(1):75-86. PubMed ID: 26667418
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice.
Tran HT; Sanchez L; Brody DL
J Neuropathol Exp Neurol; 2012 Feb; 71(2):116-29. PubMed ID: 22249463
[TBL] [Abstract][Full Text] [Related]
16. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
17. Juvenile Traumatic Brain Injury Results in Cognitive Deficits Associated with Impaired Endoplasmic Reticulum Stress and Early Tauopathy.
Hylin MJ; Holden RC; Smith AC; Logsdon AF; Qaiser R; Lucke-Wold BP
Dev Neurosci; 2018; 40(2):175-188. PubMed ID: 29788004
[TBL] [Abstract][Full Text] [Related]
18. Tau Oligomers Derived from Traumatic Brain Injury Cause Cognitive Impairment and Accelerate Onset of Pathology in Htau Mice.
Gerson J; Castillo-Carranza DL; Sengupta U; Bodani R; Prough DS; DeWitt DS; Hawkins BE; Kayed R
J Neurotrauma; 2016 Nov; 33(22):2034-2043. PubMed ID: 26729399
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta and tau pathology following repetitive mild traumatic brain injury.
Edwards G; Moreno-Gonzalez I; Soto C
Biochem Biophys Res Commun; 2017 Feb; 483(4):1137-1142. PubMed ID: 27492070
[TBL] [Abstract][Full Text] [Related]
20. Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model.
Tagge CA; Fisher AM; Minaeva OV; Gaudreau-Balderrama A; Moncaster JA; Zhang XL; Wojnarowicz MW; Casey N; Lu H; Kokiko-Cochran ON; Saman S; Ericsson M; Onos KD; Veksler R; Senatorov VV; Kondo A; Zhou XZ; Miry O; Vose LR; Gopaul KR; Upreti C; Nowinski CJ; Cantu RC; Alvarez VE; Hildebrandt AM; Franz ES; Konrad J; Hamilton JA; Hua N; Tripodis Y; Anderson AT; Howell GR; Kaufer D; Hall GF; Lu KP; Ransohoff RM; Cleveland RO; Kowall NW; Stein TD; Lamb BT; Huber BR; Moss WC; Friedman A; Stanton PK; McKee AC; Goldstein LE
Brain; 2018 Feb; 141(2):422-458. PubMed ID: 29360998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
